Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent:a case-control study

Peer Review reports

Original Submission
9 Oct 2012	Submitted	Original manuscript
25 Oct 2012	Reviewed	Reviewer Report - Dminika Wokolorczyk
29 Oct 2012	Reviewed	Reviewer Report - Rodney Scott
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
29 Oct 2012	Editorially accepted
20 Nov 2012	Article published	10.1186/1897-4287-10-16

Back to article page